Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Medical Bionics Market by Type (Vision Bionics/Bionic Eye, Ear Bionics, Orthopedic Bionics, Cardiac Bionics and Neural Bionics), and Method of Fixation (Implantable Bionics and External Bionics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

A01841

Pages: 180

Charts: 65

Tables: 51

Medical Bionics Market Overview:

Global Medical Bionics Market was valued at $15,348 million in 2016, and is expected to garner $29,160 million by 2023, registering a CAGR of 9.6% during the forecast period. Bionics also known as biomedical implants are artificial addition to the body. These artificial implants mimic the function of the lost or non-functional body part such as limb or eye. Rise in geriatric population, increase in government focus on funding R&D initiatives, and upsurge in number of patients suffering from chronic diseases are expected to drive the market growth. Moreover, technological advancements, such as the cochlear implants, with speech recognition features that help to differentiate speech in noisy and reverberant situation fuel the demand for medical bionics. However, high cost of the devices and treatment and stringent approval process for these devices are expected to impede the market growth.

Get more information on this report : Request Sample Pages

Rise in Incidence of Chronic Disease

As per the estimates of the annual report (2014) published by the American Heart Association in Heart Ware International, Inc., approximately 5.5 million individuals are affected by heart failure in the U.S. Moreover, approximately 670,000 new cases of heart failure are diagnosed each year in the U.S. Similarly, in Canada there is a rise in the prevalence of chronic diseases due to unhealthy lifestyle and aging population. In 2007, 1.3 million Canadians were reported to be diagnosed with heart diseases, around 1.6 million were reported to be living with the effects of stroke (Source: Public Health Agency of Canada).

Growth in Asia-Pacific Region

This region offers lucrative opportunities in this market owing to presence of large pool of patients suffering from chronic disorders such as cardiac disorders, neural disorders and hearing and vision loss. In 2011, the Australian Institute of Health & Welfare estimated that at least 300,000 Australians have suffered from chronic heart failure and 30,000 new cases are identified every year. Hence, high incidence of cardiac disorders makes it an attractive market for cardiac bionics. In addition, high prevalence of eye-related diseases in Japan makes it an attractive market for eye bionics in the country.

Leading Causes of Blindness in Japan, 2013

Get more information on this report : Request Sample Pages

Technological Advancements Witnessed in the Market

The field of medical bionics have witnessed several technological advancements in the recent years. The cochlear implants available in the present scenario have speech recognition in difficult listening situations, which help to differentiate speech in noisy and reverberant situation, understand sound from television or telephone, and identify a sound from distance. In addition, hearing aids feature acoustic scene classifiers, which help hearing aids to classify and identify any sound based on background noise, speech in quiet or in noise, music, wind, and number of other parameters.

South Africa: Medical Bionics Market, ($Million) 2016-2023

Get more information on this report : Request Sample Pages

Segmentation

Get more information on this report : Request Sample Pages

The key companies operating in the medical bionics market are Abbott, Boston Scientific Corporation, Cochlear Ltd., LivaNova PLC, Medtronic plc, Orthofix Holdings, Inc., ssur Corporate, Retina Implant AG, Sonova, SECOND SIGHT, SynCardia Systems, LLC, and William Demant Holding A/S

Key Benefits

  • The study provides an in-depth analysis of the global medical bionics market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Medical Bionics Market Key Segments:

By Product

  • Vision Bionics/Bionic Eye
  • Ear Bionics
    • Cochlear Implants
    • Bone Anchored Hearing Systems
    • Auditory Brainstem Implants
  • Orthopedic Bionics
    • Upper limb
    • Lower limb
      • Bionic Knee
      • Bionic Feet
    • Exoskeleton
    • Electrical Bone Growth Stimulators
      • Invasive Bone Growth Stimulators
      • Non-Invasive Bone Growth Stimulators
  • Cardiac Bionics
    • Pacemaker
    • Total Artificial Heart
    • Ventricular Assist Device
      • Left Ventricular Assist Device (LVAD)
      • Right Ventricular Assist Device (RVAD)
      • Biventricular Assist Device (BIVAD)
    • Artificial Heart Valves
      • Mechanical Heart Valves
      • Tissue Heart Valves
  • Neural/Brain Bionics
    • Internal Neurostimulators
      • Deep Brain Stimulators (DBS)
      • Sacral Nerve Stimulators (SNS)
      • Vagus Nerve Stimulators (VNS)
      • Spinal Cord Stimulators (SCS)
      • Other Neurostimulators
    • External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

By Method of Fixation

  • Implantable Bionics
  • External Bionics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Segments

  • By PRODUCT
    • VISION BIONICS/ BIONICS EYE
    • EAR BIONICS
      • Cochlear Implants
      • Bone Anchored Hearing Systems
      • Auditory Brainstem Implants
    • ORTHOPEDIC BIONICS
      • Upper limb
      • Lower limb
        • Bionic Knee
        • Bionic Feet
      • Exoskeleton
      • Electrical Bone Growth Stimulators
        • Invasive Bone Growth Stimulators
        • Non-Invasive Bone Growth Stimulators
    • CARDIAC BIONICS
      • Pacemaker
      • Total Artificial Heart
      • Ventricular Assist Device
        • Left Ventricular Assist Device (LVAD)
        • Right Ventricular Assist Device (RVAD)
        • Biventricular Assist Device (BIVAD)
      • Artificial Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
    • NEURAL/BRAIN BIONICS
      • Internal Neurostimulators
        • Deep Brain Stimulators (DBS)
        • Sacral Nerve Stimulators (SNS)
        • Vagus Nerve Stimulators (VNS)
        • Spinal Cord Stimulators (SCS)
        • Other Neurostimulators
      • External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
  • By METHOD OF FIXATION
    • IMPLANTABLE BIONICS
    • EXTERNAL BIONICS
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA


Key Market Players

  • ABOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • SYNCARDIA SYSTEMS, LLC
  • MEDTRONIC PLC
  • RETINA IMPLANT AG
  • OSSUR
  • ORTHOFIX HOLDINGS, INC.
  • COCHLEAR LTD.
  • SONOVA
  • LIVANOVA PLC
  • SECOND SIGHT MEDICAL PRODUCTS, INC.
  • WILLIAM DEMANT HOLDING A/S

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in number of patients suffering from chronic diseases
3.3.1.2. Increasing pool of geriatric population
3.3.1.3. Technological advancements
3.3.1.4. Increasing government focus on funding R&D initiatives

3.3.2. Restraints

3.3.2.1. High cost of treatment
3.3.2.2. Stringent approval process

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies

3.3.4. Impact Analysis

3.4. GOVERNMENT REGULATIONS
3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. VISION BIONICS/ BIONICS EYE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EAR BIONICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Cochlear implants
4.3.3.2. Market size and forecast
4.3.3.3. Bone Anchored Hearing Systems (BAHS)
4.3.3.4. Market size and forecast
4.3.3.5. Auditory brainstem implants
4.3.3.6. Market size and forecast

4.4. ORTHOPEDIC BIONICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.4.3.1. Upper limb
4.4.3.2. Market size and forecast
4.4.3.3. Lower limb
4.4.3.4. Market size and forecast

4.4.3.4.1. Bionic knee
4.4.3.4.2. Market size and forecast
4.4.3.4.3. Bionic feet
4.4.3.4.4. Market size and forecast

4.4.3.5. Exoskeleton
4.4.3.6. Market size and forecast
4.4.3.7. Electrical bone growth stimulators
4.4.3.8. Market size and forecast

4.4.3.8.1. Invasive bone growth stimulators
4.4.3.8.2. Market size and forecast
4.4.3.8.3. Non-invasive bone growth stimulators
4.4.3.8.4. Market size and forecast

4.5. CARDIAC BIONICS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Pacemaker

4.5.4.1. Implantable pacemaker
4.5.4.2. External pacemaker

4.5.5. Market size and forecast
4.5.6. Total artificial heart
4.5.7. Market size and forecast
4.5.8. Ventricular assist device (VADs)
4.5.9. Market size and forecast

4.5.9.1. Left Ventricular Assist Device (LVAD)
4.5.9.2. Market size and forecast
4.5.9.3. Right Ventricular Assist Device (RVAD)
4.5.9.4. Market size and forecast
4.5.9.5. Biventricular Assist Device (BIVAD)
4.5.9.6. Market size and forecast

4.5.10. Artificial Heart Valves
4.5.11. Market size and forecast

4.5.11.1. Mechanical Heart Valves
4.5.11.2. Market size and forecast
4.5.11.3. Tissue Heart Valves
4.5.11.4. Market size and forecast

4.6. NEURAL/BRAIN BIONICS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Internal Neurostimulators
4.6.5. Market size and forecast

4.6.5.1. Deep Brain Stimulators (DBS)
4.6.5.2. Market size and forecast
4.6.5.3. Sacral Nerve Stimulators (SNS)
4.6.5.4. Market size and forecast
4.6.5.5. Vagus Nerve Stimulators (VNS)
4.6.5.6. Market size and forecast
4.6.5.7. Spinal Cord Stimulators (SCS)
4.6.5.8. Market size and forecast
4.6.5.9. Other Neurostimulators
4.6.5.10. Market size and forecast

4.6.6. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.6.7. Market size and forecast

CHAPTER 5 GLOBAL MEDICAL BIONICS MARKET, BY METHOD OF FIXATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. IMPLANTABLE BIONICS

5.2.1. Market size and forecast

5.3. EXTERNAL BIONICS

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL MEDICAL BIONICS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. India market size and forecast
6.4.7. Australia market size and forecast
6.4.8. Malaysia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. South Africa market size and forecast
6.5.6. Saudi Arabia market size and forecast
6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ABOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)

7.2. BOSTON SCIENTIFIC CORPORATION

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)

7.3. COCHLEAR LTD.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)

7.4. LIVANOVA PLC

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)

7.5. MEDTRONIC PLC

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)

7.6. ORTHOFIX HOLDINGS, INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)

7.7. OSSUR

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)

7.8. RETINA IMPLANT AG

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)

7.9. SONOVA

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)

7.10. SECOND SIGHT MEDICAL PRODUCTS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)

7.11. SYNCARDIA SYSTEMS, LLC

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves and developments
7.11.6. Strategy share (%)

7.12. WILLIAM DEMANT HOLDING A/S

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments
7.12.6. Strategy share (%)

LIST OF TABLES

TABLE 1. NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 2. GLOBAL MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. GLOBAL ORTHOPEDIC BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4. GLOBAL EAR BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5. GLOBAL CARDIAC BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6. GLOBAL PACEMAKERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 7. GLOBAL VADS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8. GLOBAL ARTIFICIAL HEART VALVES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 9. GLOBAL NEURAL/BRAIN BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 10. GLOBAL INTERNAL NEURAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 11. GLOBAL MEDICAL BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 12. NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 13. EUROPE MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 14. ASIA-PACIFIC MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. LAMEA MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 16. GLOBAL VISION BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL EAR BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 18. GLOBAL ORTHOPEDIC BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 19. GLOBAL CARDIAC BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 20. GLOBAL NEURAL BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 21. NORTH AMERICA MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 22. EUROPE MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 23. ASIA-PACIFIC MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 24. LAMEA MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 25. GLOBAL MEDICAL BIONICS MARKET, BY FIXATION, 2014-2022 ($MILLION)
TABLE 26. GLOBAL EXTERNAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 27. GLOBAL IMPLANTABLE BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 28. ABOTT: COMPANY SNAPSHOT
TABLE 29. ABOTT: OPERATING SEGMENTS
TABLE 30. BOSTON : COMPANY SNAPSHOT
TABLE 31. BOSTON : OPERATING SEGMENTS
TABLE 32. COCHLEAR : COMPANY SNAPSHOT
TABLE 33. COCHLEAR : OPERATING SEGMENTS
TABLE 34. LIVANOVA: COMPANY SNAPSHOT
TABLE 35. LIVANOVA: OPERATING SEGMENTS
TABLE 36. MEDTRONIC: COMPANY SNAPSHOT
TABLE 37. MEDTRONIC: OPERATING SEGMENTS
TABLE 38. ORTHOFIX: COMPANY SNAPSHOT
TABLE 39. ORTHOFIX: OPERATING SEGMENTS
TABLE 40. OSSUR: COMPANY SNAPSHOT
TABLE 41. OSSUR: OPERATING SEGMENTS
TABLE 42. RETINA: COMPANY SNAPSHOT
TABLE 43. RETINA: OPERATING SEGMENTS
TABLE 44. SONOVA: COMPANY SNAPSHOT
TABLE 45. SONOVA: OPERATING SEGMENTS
TABLE 46. SECOND SIGHT: COMPANY SNAPSHOT
TABLE 47. SECOND SIGHT: OPERATING SEGMENTS
TABLE 48. SYNCARDIA: COMPANY SNAPSHOT
TABLE 49. SYNCARDIA: OPERATING SEGMENTS
TABLE 50. WILLIAM: COMPANY SNAPSHOT
TABLE 51. WILLIAM: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. MEDICAL BIONICS MARKET SEGMENTATION
FIGURE 2. MARKET SHARE ANALYSIS, CARDIAC BIONICS, 2016
FIGURE 3. MARKET SHARE ANALYSIS, NEURAL/BRAIN BIONICS, 2016
FIGURE 4. MARKET SHARE ANALYSIS, EAR BIONICS MARKET, 2016
FIGURE 5. DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2012
FIGURE 6. CLINICAL TRIALS IN MEDICAL BIONICS MARKET, BY REGION
FIGURE 7. CLINICAL TRIALS FOR MEDICAL DEVICES (%)
FIGURE 8. U.S. MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 9. CANADA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 10. MEXICO MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 11. GERMANY MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 12. FRANCE MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 13. UK MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 14. ITALY MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 15. SPAIN MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 16. REST OF EUROPE MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 17. LEADING CAUSES OF BLINDNESS IN JAPAN, 2013
FIGURE 18. JAPAN MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 19. CHINA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 20. INDIA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 21. AUSTRALIA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 22. MALAYSIA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 23. REST OF ASIA-PACIFIC MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 24. GLOBAL MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 25. GLOBAL ORTHOPEDIC BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 26. GLOBAL EAR BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 27. GLOBAL CARDIAC BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 28. GLOBAL PACEMAKERS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 29. GLOBAL VADS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 30. GLOBAL ARTIFICIAL HEART VALVES MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 31. GLOBAL NEURAL/BRAIN BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 32. GLOBAL INTERNAL NEURAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 33. GLOBAL MEDICAL BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 34. NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 35. EUROPE MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 36. ASIA-PACIFIC MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 37. LAMEA MEDICAL BIONICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 38. GLOBAL VISION BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 39. GLOBAL EAR BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 40. GLOBAL ORTHOPEDIC BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 41. GLOBAL CARDIAC BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 42. GLOBAL NEURAL BIONICS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 43. NORTH AMERICA MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 44. EUROPE MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 45. ASIA-PACIFIC MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 46. LAMEA MEDICAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 47. GLOBAL MEDICAL BIONICS MARKET, BY FIXATION, 2014-2022 ($MILLION)
FIGURE 48. GLOBAL EXTERNAL BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 49. GLOBAL IMPLANTABLE BIONICS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIGURE 50. BRAZIL MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 51. SOUTH AFRICA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 52. SAUDI ARABIA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 53. REST OF LAMEA MEDICAL BIONICS MARKET, 2016-2023($MILLION)
FIGURE 54. ABOTT: FINANCIALS
FIGURE 55. BOSTON : FINANCIALS
FIGURE 56. COCHLEAR : FINANCIALS
FIGURE 57. LIVANOVA: FINANCIALS
FIGURE 58. MEDTRONIC: FINANCIALS
FIGURE 59. ORTHOFIX: FINANCIALS
FIGURE 60. OSSUR: FINANCIALS
FIGURE 61. RETINA: FINANCIALS
FIGURE 62. SONOVA: FINANCIALS
FIGURE 63. SECOND SIGHT: FINANCIALS
FIGURE 64. SYNCARDIA: FINANCIALS
FIGURE 65. WILLIAM: FINANCIALS

Purchase Full Report of
Medical Bionics Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue